Scientists at the Okinawa Institute of Science and Technology Graduate University (OIST) have developed technology that is in fact throwing light on certain smallest particles to detect their presence — and it is developed from tiny glass bubbles.
The technology is based on a unique physical phenomenon called the “whispering gallery,” described by physicist Lord Rayleigh (John William Strutt) in 1878 and named after an acoustic effect inside the dome of St Paul’s Cathedral in London. It was possible to clearly hear the whispers made at one side of the circular gallery at the opposite side. This is due to the travel of sound waves along the walls of the dome to the other side. This effect can be reproduced by light in a tiny glass sphere with a width just equal to the breadth a strand of hair, known as a Whispering Gallery Resonator (WGR).
Upon shining light into the sphere, it bounces around the inner surface again and again, forming an optical carousel. Photons that bounce along the inner surface of the tiny sphere can end up traveling for long distances, as long as 100 m at times. However, every time a photon gets bounced off the surface of the sphere, a small amount of light escapes. This leaking light forms a kind of aura around the sphere, called as an evanescent light field.
When nanoparticles enter the range of this field, its wavelength is distorted by them, thus effectively altering its color. Researchers can monitor these changes in color and use the WGRs as a sensor; earlier, different research teams used them to detect individual virus particles in solution, for instance. However, researchers at OIST’s Light-Matter Interactions Unit observed that enhancements to prior work can be made to develop even more sensitive designs. The research has been reported in the journal Optica.
Image Credit: OIST
News This Week
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]








Leave A Comment